(Date:11/9/2009)..., Lung Cancer Awareness Month Highlighted Du...re-USNewswire/ -- Lung Cancer Alliance (LCA) annou...ng The Closing Bell for the New York Stock Exchang..., (Logo: http://www.newscom.com/cgi-bin/prnh/200...ancer survivor and LCA-NY advocate, Richard Heimle...
(Date:11/9/2009)..., SBA Provision, Antitrust Language, Federal... in Senate ,, WASHINGTON, Nov. 9 /PRNewswire-U...rdable Health Care for America Act (H.R. 3962) all...ered by health insurance exchanges is positive, bu...e, according to the National Association of Profes...
(Date:11/9/2009)... Study in mice reports success with drugs that inh...thDay News) -- Two drugs used to treat breast canc...mice, according to a new study. , The drugs als...agina, and prevented the onset of cancer in mice w...rug fulvestrant and the breast cancer/osteoporosis...
(Date:11/9/2009)..., Networking is everybody... it means Money. StaffingClub.com enables Recruite...f contacts to connect, share, communicate and clos...Seekers to post their profiles and network with re...ber 9, 2009 -- Current Job Market forces everyone ...
(Date:11/9/2009)... Rabbits implanted with new cells regained sexual .... 9 (HealthDay News) -- Researchers were able to r...ises by growing new penile tissue in the lab and i...uman application is a ways off, researchers say th...erectile dysfunction in men. , "We were able to...
Breaking Medicine News(10 mins):Health News:Lung Cancer Alliance Staff and Advocates to Ring Closing Bell of New York Stock Exchange(TM) 2Health News:PIA Says Inclusion of Agents in House Healthcare Bill is Positive, But Concerns Remain 2Health News:PIA Says Inclusion of Agents in House Healthcare Bill is Positive, But Concerns Remain 3Health News:Breast Cancer Drugs May Fight Cervical Cancer, Too 2Health News:Launching StaffingClub.com, a New Online Networking Platform for Recruiting and Staffing Professionals 2Health News:Scientists Grow New Penile Tissue in the Lab 2Health News:Scientists Grow New Penile Tissue in the Lab 3(Date:11/9/2009)...re-FirstCall/ -- Par Pharmaceutical Companies, Inc...ed the expiration date and increased the purchase ...Auction" tender offer, in which Par is offering to...rincipal amount, or up to approximately 82.7%, of ...ible Notes due 2010. ,, The price for the offer...
(Date:11/9/2009)...rstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ...ird quarter ended September 30, 2009. ,, Arena ...kholders in the third quarter of 2009 of $34.8 mil...llocable to common stockholders in the third quart...nd a net loss allocable to common stockholders in ...
(Date:11/9/2009)...Groundbreaking articles in current issues of Jou...plore, in depth, the emergence of cannabinoid medi... its potential benefits for patients. ,, In the...thors, Sunil Aggarwal, PhD who is a member of the ... who conducted the article,s research and Gregory ...
Breaking Medicine Technology:Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Note 2Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Note 3Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 2Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 3Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 4Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 5Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 6Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 7Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 8Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 9Medicinal Use of Marijuana: Past, Present and Future...A Fresh Look by Experts in the Field 2Laurence I Barsh DMD Founder of Snoring Isn 26apos 3Bt Sexy to speak at Somnomed 26apos 3Bs First Annual Symposium 53426 1Laurence I Barsh DMD Founder of Snoring Isn 26apos 3Bt Sexy to speak at Somnomed 26apos 3Bs First Annual Symposium 53426 2Online H1N1 Management 3A FairChoice Helps Schools Respond to Infectious Disease on Campus 4806 1GAA Calls on Secretary Clinton to Speak Out Against Gender Based Violence During Her Africa Trip 4805 1GAA Calls on Secretary Clinton to Speak Out Against Gender Based Violence During Her Africa Trip 4805 2...ticals,Inc., a privately held biopharmaceutical co...d today that the U.S. Food and Drug,Administration...anted A-001,orphan drug status for the prevention ...ll disease., A-001 is currently being evaluated f...al in the United States called IMPACTS (Investigat...
...n,(Nasdaq: DRRX ) announced today positive result...DURECT,s proprietary investigational transdermal p...m post-herpetic neuralgia,ELADUR showed improved p...uous treatment period. In addition, ELADUR appeare...h ELADUR and placebo exhibited similar,safety prof...
Other Medicine Technology:Anthera's A-001 Receives Orphan Drug Status for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease 2Anthera's A-001 Receives Orphan Drug Status for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease 3DURECT Announces Positive ELADUR(TM) Phase IIa Study Results 2DURECT Announces Positive ELADUR(TM) Phase IIa Study Results 3Micro Needle Holders With Lock
Vascular Clamps HD-S
Yasargil Spring Hool with Bulldog Clamp
Micro Picks
Medicine Products: